Drug information for SEROSTIM
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
4MG/VIAL
Prescription
BX
SOMATROPIN RECOMBINANT
Human Growth Hormone
EMD SERONO
20604
2012-04-06 Label
2012-04-05 Letter
2011-02-15 Review
2009-11-19 Letter
2009-09-16 Review
2009-09-16 Review
2007-09-04 Letter
2007-09-04 Label
2007-08-30 Letter
2007-08-30 Label
2007-08-06 Review
2007-07-24 Letter
2007-07-16 Label
2006-12-04 Label
2006-12-04 Letter
2006-09-25 Letter
2006-09-25 Label
2005-08-31 Label
2005-08-31 Letter
2005-02-17 Label
2005-02-17 Letter
2004-07-14 Label
2004-07-14 Letter
2003-12-08 Label
2003-12-04 Letter
2003-09-09 Letter
2003-09-09 Label
INJECTABLE; INJECTION
5MG/VIAL
Prescription
BX
SOMATROPIN RECOMBINANT
Human Growth Hormone
EMD SERONO
"
INJECTABLE; INJECTION
6MG/VIAL
Prescription
BX
SOMATROPIN RECOMBINANT
Human Growth Hormone
EMD SERONO
"
INJECTABLE; INJECTION
8.8MG/VIAL
Discontinued
SOMATROPIN RECOMBINANT
Human Growth Hormone
EMD SERONO
"
Drug Adverse Effects information for SEROSTIM
Role code
Indications
Reaction
# Reports
PS
ANTIRETROVIRAL THERAPY
DEVICE RELATED INFECTION
5
PS
ANTIRETROVIRAL THERAPY
NEPHROLITHIASIS
5
PS
CACHEXIA
DEATH
1
PS
CACHEXIA
MACULAR HOLE
1
PS
HIV INFECTION
NASOPHARYNGITIS
5
PS
HIV WASTING SYNDROME
CHOLECYSTITIS
1
PS
HIV WASTING SYNDROME
CHOLELITHIASIS
1
PS
HIV WASTING SYNDROME
DEMENTIA
1
PS
HIV WASTING SYNDROME
EYE SWELLING
1
PS
HIV WASTING SYNDROME
NASOPHARYNGITIS
1
PS
HIV WASTING SYNDROME
OXYGEN SATURATION DECREASED
1
PS
HIV WASTING SYNDROME
PANCREATITIS
2
PS
LENTIVIRUS TEST POSITIVE
DEVICE RELATED INFECTION
1
PS
LENTIVIRUS TEST POSITIVE
NEPHROLITHIASIS
1
SS
HIV WASTING SYNDROME
CHOLECYSTITIS
2
SS
HIV WASTING SYNDROME
CHOLELITHIASIS
2
SS
HIV WASTING SYNDROME
EYE SWELLING
2
SS
HIV WASTING SYNDROME
PANCREATITIS
2
C
LIPODYSTROPHY ACQUIRED
MYOCARDIAL INFARCTION
1
Ads by Google